Back to DatabaseFDA Approved
SS-31
Also known as: Elamipretide, Bendavia, MTP-131, D-Arg-dimethylTyr-Lys-Phe-NH2
Anti-Aging
Approved
SS-31 (Elamipretide) is a breakthrough mitochondria-targeted peptide that selectively concentrates in the inner mitochondrial membrane, where it protects cardiolipin — a unique phospholipid essential for mitochondrial energy production and cellular viability. It is the most advanced mitochondria-targeting therapeutic in development.
Regulatory & Approval Status
SS-31 (elamipretide) has received FDA accelerated approval for the treatment of Barth syndrome under the brand name Forzinity.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.